ATE274955T1 - Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken - Google Patents

Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken

Info

Publication number
ATE274955T1
ATE274955T1 AT00932001T AT00932001T ATE274955T1 AT E274955 T1 ATE274955 T1 AT E274955T1 AT 00932001 T AT00932001 T AT 00932001T AT 00932001 T AT00932001 T AT 00932001T AT E274955 T1 ATE274955 T1 AT E274955T1
Authority
AT
Austria
Prior art keywords
composition
active ingredient
medicinal compositions
aerosol formation
inhalation purposes
Prior art date
Application number
AT00932001T
Other languages
English (en)
Inventor
Rachel M Thurston
James D Browning
Praful K Shah
Michael E Placke
Original Assignee
Battelle Memorial Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute filed Critical Battelle Memorial Institute
Application granted granted Critical
Publication of ATE274955T1 publication Critical patent/ATE274955T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/02—Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B5/00—Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
    • B05B5/025—Discharge apparatus, e.g. electrostatic spray guns
    • B05B5/0255—Discharge apparatus, e.g. electrostatic spray guns spraying and depositing by electrostatic forces only

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00932001T 1999-05-03 2000-05-02 Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken ATE274955T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13221599P 1999-05-03 1999-05-03
PCT/US2000/011799 WO2000066206A2 (en) 1999-05-03 2000-05-02 Compositions for aerosolization and inhalation

Publications (1)

Publication Number Publication Date
ATE274955T1 true ATE274955T1 (de) 2004-09-15

Family

ID=22453000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00932001T ATE274955T1 (de) 1999-05-03 2000-05-02 Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken

Country Status (11)

Country Link
US (1) US6503481B1 (de)
EP (1) EP1173245B1 (de)
JP (1) JP2002543165A (de)
AT (1) ATE274955T1 (de)
AU (1) AU4979700A (de)
BR (1) BR0010262A (de)
CA (1) CA2370853C (de)
DE (1) DE60013425T2 (de)
ES (1) ES2226843T3 (de)
MX (1) MXPA01011283A (de)
WO (1) WO2000066206A2 (de)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2345010B (en) * 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
WO2001051030A1 (en) * 2000-01-10 2001-07-19 Dura Pharmaceuticals, Inc. Pharmaceutical formulation and method for pulmonary and oral delivery
DE60138535D1 (de) * 2000-02-04 2009-06-10 Children S Hospital Res Founda Verwendung von lysosomal acid lipase zur behandlung von atherosklerose und ähnlichen krankheiten
AU2001244391B9 (en) * 2000-04-03 2006-10-05 Ventaira Pharmaceuticals, Inc. Devices and formulations
EP1343521A2 (de) * 2000-12-01 2003-09-17 Battelle Memorial Institute Verfahren zur stabilisierung von biomolekülen (z.b. insulin) in flüssigen formulierungen
US7891578B2 (en) 2001-03-22 2011-02-22 Battelle Memorial Institute Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
US6759029B2 (en) 2001-05-24 2004-07-06 Alexza Molecular Delivery Corporation Delivery of rizatriptan and zolmitriptan through an inhalation route
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
JP4357842B2 (ja) 2001-05-24 2009-11-04 アレックザ ファーマシューティカルズ， インコーポレイテッド 所定の吸入ルートによるアルプラゾラム、エスタゾラム、ミダゾラムまたはトリアゾラムの送出
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
US6805853B2 (en) 2001-11-09 2004-10-19 Alexza Molecular Delivery Corporation Delivery of diazepam through an inhalation route
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
JP2005527639A (ja) 2001-11-02 2005-09-15 インサート セラピューティクス インコーポレイテッド Ｒｎａ干渉の治療的利用のための方法及び組成物
BR0214280A (pt) * 2001-11-19 2005-01-11 Becton Dickinson Co Composição farmacêuticas em forma particulada
EP1446102A1 (de) 2001-11-21 2004-08-18 Alexza Molecular Delivery Corporation Verabreichung von koffein durch inhalation
EP2098113A3 (de) 2002-10-25 2010-12-29 Battelle Memorial Institute Elekrohydrodynamisches Spray zur Behandlung von nicht-menschlichen Tieren
US7550133B2 (en) 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US6982004B1 (en) 2002-11-26 2006-01-03 Advanced Cardiovascular Systems, Inc. Electrostatic loading of drugs on implantable medical devices
US7849850B2 (en) * 2003-02-28 2010-12-14 Battelle Memorial Institute Nozzle for handheld pulmonary aerosol delivery device
US20040187864A1 (en) * 2003-03-24 2004-09-30 Cindet, Llc Inhalation device and method
CA2526478A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Methods of controlling uniformity of substrate temperature and self-contained heating unit and drug-supply unit employing same
FR2855069B1 (fr) * 2003-05-22 2006-06-16 Solvay Procede pour la separation d'au moins un compose organique
DE602004025151D1 (de) * 2004-03-10 2010-03-04 Shimoda Biotech Pty Ltd Stabile injizierbare Diclofenac- Zubereitungen
KR20050099311A (ko) * 2004-04-09 2005-10-13 에이엔에이치 케어연구소(주) 주사제용 항암제 조성물
BRPI0510119A (pt) 2004-04-23 2007-09-25 Cydex Inc formulação para dpi contendo sulfoaquil éter de ciclodextrina
CA2567334A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20080259519A1 (en) * 2004-09-14 2008-10-23 Battelle Memorial Institute Highly-Aqueous, Non-Respirable Aerosols Containing Biologically-Active Ingredients, Method of Making, and Device Therefor
PL1866414T3 (pl) 2005-03-31 2012-10-31 Calando Pharmaceuticals Inc Inhibitory podjednostki 2 reduktazy rybonukleotydowej i ich zastosowania
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
WO2006125153A2 (en) * 2005-05-18 2006-11-23 Pulmatrix Inc. Formulations for alteration of biophysical properties of mucosal lining
US20090297496A1 (en) * 2005-09-08 2009-12-03 Childrens Hospital Medical Center Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
SI2952197T1 (sl) 2005-10-26 2017-09-29 Cydex Pharmaceuticals, Inc. Sestavki sulfoalkil eter ciklodekstrina in metode priprave le-tega
EP2202239A1 (de) 2005-11-01 2010-06-30 Alnylam Pharmaceuticals Inc. RNAi-Hemmung von Influenza-Virus-Neubildungen
WO2007083164A2 (en) * 2006-01-17 2007-07-26 Aerstream Technology Limited Liquid electrostatic spray composition
EP2018224B1 (de) 2006-02-14 2019-03-06 EField Innovations LLC Ehd-zerstäuber mit getrennter entladung und schutz vor elektrischem feld
WO2007109097A2 (en) 2006-03-16 2007-09-27 Alnylam Pharmaceuticals, Inc. RNAi MODULATION OF TGF-BETA AND THERAPEUTIC USES THEREOF
JP2007254421A (ja) * 2006-03-24 2007-10-04 Canon Inc 吐出用液体、吐出方法、吐出用カートリッジ、吐出装置及び吐出用液体の液滴化方法
EP2392583A1 (de) 2006-05-19 2011-12-07 Alnylam Europe AG. RNAi-Modulation von AHA und therapeutische Verwendungen davon
US20090054333A1 (en) * 2006-10-17 2009-02-26 Antonio Giordano Peptide inhibitors of cyclin-dependent kinase activity and uses thereof
CA2676979A1 (en) * 2007-02-01 2008-08-07 Batelle Memorial Institute Compositions for aerosolization of highly conductive solutions
WO2008106646A2 (en) * 2007-03-01 2008-09-04 Introgen Therapeutics, Inc Methods and formulations for topical gene therapy
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
PL2265309T3 (pl) * 2008-03-17 2016-06-30 Discovery Lab Inc Adapter obwodu oddechowego i proksymalny system podawania aerozolu
JP2011516065A (ja) 2008-04-04 2011-05-26 カランド ファーマシューティカルズ， インコーポレイテッド Ｅｐａｓ１阻害剤の組成物および使用
CA2683353C (en) 2008-10-22 2015-12-15 Trudell Medical International Modular aerosol delivery system
CA2762620A1 (en) 2009-05-29 2010-12-02 Sumitomo Chemical Company, Limited Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
US20110174304A1 (en) * 2010-01-21 2011-07-21 Triplett Ii Michael D Electrohydrodynamic aerosolization device having a time varying voltage
US20120048963A1 (en) 2010-08-26 2012-03-01 Alexza Pharmaceuticals, Inc. Heat Units Using a Solid Fuel Capable of Undergoing an Exothermic Metal Oxidation-Reduction Reaction Propagated without an Igniter
WO2012030664A1 (en) 2010-08-30 2012-03-08 Pulmatrix, Inc. Dry powder formulations and methods for treating pulmonary diseases
US8758824B2 (en) 2010-08-30 2014-06-24 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
EP4008326A1 (de) 2010-09-29 2022-06-08 Pulmatrix Operating Company, Inc. Einwertige metallkationen-trockenpulver zum inhalieren
PT2621488T (pt) 2010-09-29 2019-02-12 Pulmatrix Operating Co Inc Pós secos catiónicos
EP2658584A1 (de) * 2010-12-28 2013-11-06 Sumitomo Chemical Company Limited Verfahren zur behandlung eines zielraums und flüssigpartikel
AU2011265562A1 (en) 2011-01-12 2012-07-26 Sumitomo Chemical Company, Limited Method of controlling harmful arthropod, composition, and electrostatic spray device
US20120302954A1 (en) * 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
JP2013070767A (ja) * 2011-09-27 2013-04-22 Panasonic Corp 機能性微粒子放出装置
BR112014009866A2 (pt) 2011-10-25 2018-09-04 Onclave Therapeutics Limited formulações de anticorpos e métodos
US20150136130A1 (en) 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
KR20150135328A (ko) 2013-04-01 2015-12-02 풀매트릭스 인코퍼레이티드 티오트로피움 건조 분말
US9802010B2 (en) * 2013-11-22 2017-10-31 Noveome Biotherapeutics, Inc. Interproximal drug delivery device
JP2017505348A (ja) 2014-02-10 2017-02-16 パタラ ファーマ リミテッド ライアビリティ カンパニー 肺疾患治療のための肥満細胞安定剤
PL3104853T3 (pl) 2014-02-10 2020-05-18 Respivant Sciences Gmbh Leczenie stabilizatorami komórek tucznych zaburzeń ogólnoustrojowych
BR112017002356A2 (pt) * 2014-08-08 2017-11-28 Shanghai Hightide Biopharmaceutical Ltd composições de formulação líquida, dispositivos de entrega de medicamento e métodos para preparação e uso dos mesmos
SI3268072T1 (sl) 2015-03-11 2024-03-29 Alexza Pharmaceuticals, Inc. Uporaba antistatičnih materialov v dovodu zraka za proces toplotne kondenzacije aerosolov
GB201509820D0 (en) * 2015-05-06 2015-07-22 Nicoventures Holdings Ltd Aerosol delivery device
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
WO2017027387A1 (en) 2015-08-07 2017-02-16 Patara Pharma, LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (de) 2016-10-07 2020-06-03 Respivant Sciences GmbH Cromolynzusammensetzung zur behandlung von lungenfibrose
MX2020007997A (es) 2018-02-02 2020-12-03 Alexza Pharmaceuticals Inc Dispositivo electrico de aerosol de condensacion.
WO2021158463A1 (en) 2020-02-03 2021-08-12 Palatin Technologies, Inc. Diamine-linked receptor-specific cyclic peptides
CN117396502A (zh) 2021-02-09 2024-01-12 佐治亚大学研究基金会有限公司 针对肺炎球菌抗原的人类单克隆抗体
EP4507720A1 (de) 2022-04-14 2025-02-19 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Alpha-1-antitrypsin zur behandlung von paramyxoviridae- oder orthomyxoviridae-infektionen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152446B1 (de) 1983-08-18 1988-12-21 Imperial Chemical Industries Plc Elektrostatisches zerstäubungsverfahren und vorrichtung zu dessen durchführung
GB8604328D0 (en) 1986-02-21 1986-03-26 Ici Plc Producing spray of droplets of liquid
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
GB9226717D0 (en) 1992-12-22 1993-02-17 Coffee Ronald A Induction-operated electro-hydrodynamic spray device with means of modifying droplet trajectories
US6105571A (en) 1992-12-22 2000-08-22 Electrosols, Ltd. Dispensing device
US5497763A (en) 1993-05-21 1996-03-12 Aradigm Corporation Disposable package for intrapulmonary delivery of aerosolized formulations
GB9406255D0 (en) * 1994-03-29 1994-05-18 Electrosols Ltd Dispensing device
GB2327895B (en) 1997-08-08 2001-08-08 Electrosols Ltd A dispensing device
US6158431A (en) 1998-02-13 2000-12-12 Tsi Incorporated Portable systems and methods for delivery of therapeutic material to the pulmonary system
GB2334461B (en) 1998-02-20 2002-01-23 Bespak Plc Inhalation apparatus
FR2776538B1 (fr) 1998-03-27 2000-07-21 Centre Nat Rech Scient Moyens de pulverisation electrohydrodynamique
GB2345010B (en) * 1998-12-17 2002-12-31 Electrosols Ltd A delivery device
US6397838B1 (en) * 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method

Also Published As

Publication number Publication date
WO2000066206A2 (en) 2000-11-09
CA2370853C (en) 2007-07-10
BR0010262A (pt) 2002-01-15
WO2000066206A3 (en) 2001-02-08
US6503481B1 (en) 2003-01-07
MXPA01011283A (es) 2002-11-04
EP1173245A2 (de) 2002-01-23
ES2226843T3 (es) 2005-04-01
JP2002543165A (ja) 2002-12-17
AU4979700A (en) 2000-11-17
DE60013425D1 (de) 2004-10-07
CA2370853A1 (en) 2000-11-09
EP1173245B1 (de) 2004-09-01
DE60013425T2 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
DE60013425D1 (de) Arzneizusammensetzungen zur aerosolbildung und zu inhalationszwecken
DE60121857D1 (de) Arzneimittelzusammensetzung mit verzögerter Wirkstoffabgabe
DK1283700T3 (da) Farmaceutiske sustained release-præparater til parenteral administration af biologisk aktive hydrofile forbindelser
CO5280133A1 (es) Dispositivo y sistema para aerosolizar formulaciones farmaceuticas
BG105033A (bg) Фармацевтични състави за аерозоли с две, или повече активни вещества
DK1389137T3 (da) Sammensætninger til lungelægemiddellevering af protein
BRPI0314288B8 (pt) aparelhos para o envio de implantes oculares
DE60216305D1 (de) Zusammensetzungen zur verabreichung von arzneimittelkombinationen
CY1112338T1 (el) Μεθοδος παρασκευης σωματιδιων για χρηση σε φαρμακευτικη συνθεση
EA200301275A1 (ru) Капсулы для ингаляции
AR064614A1 (es) Producto combinado par controlar parasitos en animales
TW200505402A (en) Ophthalmic drug delivery device
NO20043913L (no) Blandinger med modifisert frigjoring av i det minste en form av tramadol
BR0212052A (pt) Preparação de composição farmacêutica de liberação prolongada
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
BR0116168A (pt) Formulação repelente de inseto liberável por dispositivo piezelétrico
BR0109162A (pt) Viscoelásticos para uso na cirurgia do ouvido médio
DE60128902D1 (de) Formulierungen zur verwendung in inhalationsvorrichtungen
BR0210630A (pt) Sistema fornecedor de liberação prolongada
BR0210631A (pt) Composição farmacêutica de liberação prolongada
CY1110037T1 (el) Σκευασματα για βενζιμιδαζολυλ πυριδυλ αιθερες
BR9906070A (pt) Benzamidas substituìdas
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BRPI0415505A (pt) agente terapêutico para mesotelioma
PL353738A1 (en) Composition containing an active substance, production and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties